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Abstract: Maternal perinatal nutrition may program offspring metabolic features. 
Epigenetic regulation is one of the candidate mechanisms that may be affected by maternal 
dietary methyl donors intake as potential controllers of plasma homocysteine levels. 
Thirty-two Wistar pregnant rats were randomly assigned into four dietary groups during 
lactation: control, control supplemented with methyl donors, high-fat-sucrose and  
high-fat-sucrose supplemented with methyl donors. Physiological outcomes in the 
offspring were measured, including hepatic mRNA expression and global DNA 
methylation after weaning. The newborns whose mothers were fed the obesogenic diet 
were heavier longer and with a higher adiposity and intrahepatic fat content. Interestingly, 
increased levels of plasma homocysteine induced by the maternal high-fat-sucrose  
dietary intake were prevented in both sexes by maternal methyl donors supplementation. 
Total hepatic DNA methylation decreased in females due to maternal methyl donors 
administration, while Dnmt3a hepatic mRNA levels decreased accompanying the  
high-fat-sucrose consumption. Furthermore, a negative association between Dnmt3a  
liver mRNA levels and plasma homocysteine concentrations was found. Maternal  
high-fat-sucrose diet during lactation could program offspring obesity features, while 
methyl donors supplementation prevented the onset of high hyperhomocysteinemia. 
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Maternal dietary intake also affected hepatic DNA methylation metabolism, which could 
be linked with the regulation of the methionine-homocysteine cycle. 
Keywords: cardiovascular; HFS diet; homocysteine; maternal programming;  
methyl donors; obesity 
 
1. Introduction 
Maternal environment during perinatal periods affects metabolic and physiological features of the 
offspring in adulthood [1]. One of the external factors implicated in newborns programming is 
maternal nutrition [2,3]. Pioneer epidemiological studies reported higher rates of cardiovascular 
diseases during adult life of children born around historical famines as Second World War Dutch 
famine [4] or Chinese Great Famine during 1959–1961 [5]. These investigations promoted the coining 
of the Developmental Origins of Health and Disease theory (DOHaD), which suggested that there are 
critical periods during perinatal life, in which maternal nutrition and other environmental factors 
induce changes in offspring metabolism and influence the susceptibility to suffer chronic diseases 
during the adult life [6].  
Subsequently, in order to assess the molecular mechanisms underlying DOHaD theory, the study of 
animal models has been settled as an adequate approach for the control of confounding factors, timing 
and to overcome ethical dilemmas [7,8]. Thus, epigenetic reactions have been established as putative 
regulatory mechanisms implicated in perinatal programming [1,9,10]. The term epigenetics refers to 
marks over the DNA without changes in the nucleotide sequence, affecting gene expression and 
potentially transmitted to the descendants [11]. One of the most studied epigenetic reactions is the 
methylation of CpG sites (cytosines followed by a guanine) at gene promoter regions, which can affect 
the binding of transcriptional factors to the DNA in the process of gene translation on phenotype [11]. 
Some of these reactions are mediated by DNA methyltransferases (Dnmts), whose activity depends on 
the availability of methyl donor groups and are a part of the methionine-homocysteine cycle [12].  
In this context, there are substrates implicated in this cycle, which can be provided by the diet, such as 
a cocktail including choline, betaine, folic acid and vitamin B12, which may prevent the transgenerational 
amplification of obesity by epigenetically silencing the murine agouti transposon [13]. These 
investigations demonstrated the potential regulatory role on gene expression of these substrates 
through DNA methylation. Other studies also demonstrated that reductions in the availability of 
vitamin B12, folic acid and methionine during the periconceptional time period leads to epigenetic 
modifications in the offspring and, consequently a phenotype of obesity and an associated high blood 
pressure throughout the life-course [14]. Furthermore, dietary restriction of some of these molecules in 
adult animals has been used to induce animal models of non-alcoholic fatty liver disease (NAFLD) as 
well as advanced states of steatohepatitis, cirrhosis or even hepatic carcinoma [15]. Contrariwise, 
novel studies have described the protective effect of these compounds on hepatic obesogenic  
diet-induced fat accumulation in adult male and female Wistar rats [16–18]. These studies described 
changes in liver transcriptomic and epigenetic profiles due to methyl donor supplementation, 
suggesting that this organ could be one of the main targets for methyl donor substrates. Moreover, the 
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liver is considered a major site of methionine cycle activity, playing an important role in 
homocysteinemia regulation [19]. Indeed one carbon metabolic pathway can also regulate plasma 
homocysteine levels, which are closely associated with cardiovascular diseases [20]. Some studies 
have been focused on the supplementation with specific methionine-homocysteine cycle-related 
compounds during adult life for the control of plasma homocysteine levels [21]. 
In this context, as maternal diet could affect offspring health during the whole life, this stage could 
be an adequate moment for performing interventions to prevent chronic diseases in the next generation. 
Thus, the aim of this research was to investigate the potential role of methyl donor supplementation 
during lactation in the early prevention of cardiovascular risk, by reducing hyperhomocysteinemia in 
the offspring of rats fed an obesogenic diet. 
2. Results and Discussion 
2.1. Phenotypical and Body Composition Characteristics 
In order to minimize previous confounding factors to the maternal dietary intake during lactation, 
we investigated the possible differences related with the pregnant status (Table 1). Previous studies 
have highlighted the influence of these features on offspring growth and development along life  
course [22–24]. In this way, at baseline none of the four groups of dams presented phenotypical and 
pregnancy-related differences in any of the analyzed variables, which included body weight before 
pregnancy, weight gain during pregnancy and after birth as well as intrauterine number of total, male 
and female pups.  
Table 1. Maternal perinatal features. 
 C C supp HFS HFS supp ANOVA 
Weight before pregnancy (g) 260.8 ± 13.1 269.3 ± 10.2 246.3 ± 10.9 243.8 ± 5.5 n.s. 
Weight gain during pregnancy (%) 31.4 ± 1.6 34.0 ± 2.0 34.4 ± 2.4 32.6 ± 2.5 n.s. 
Weight after birth (g) 270.5 ± 14.5 282.3 ± 8.7 267.3 ± 11.1 256.9 ± 8.3 n.s. 
Intrauterine number of pups 10.1 ± 0.8 11.5 ± 0.6 9.9 ± 0.6 9.8 ± 0.6 n.s. 
Intrauterine number of males 5.9 ± 0.8 5.5 ± 0.4 4.6 ± 0.8 4.8 ± 0.6 n.s. 
Intrauterine number of females 4.3 ± 0.4 6.0 ± 0.6 5.3 ± 0.4 5.0 ± 0.7 n.s. 
Data are reported as means ± SE (n = 8 from each experimental group). C, control; C supp, Control supplemented;  
HFS, high-fat-sucrose; HFS supp, high-fat-sucrose supplemented; n.s., non significative. 
As expected, the maternal HFS obesogenic dietary feeding induced an obese phenotype in the 
offspring in both sexes (Figure 1) characterized by increased body weight (43% in both male and 
females; p < 0.001), length (9% in males and 7% in females; p < 0.001), body fat mass (118% in males 
and 98% in females; p < 0.001) and liver fat content (35% in males and 24% in females; p < 0.001). 
Although changes in the dietary pattern could affect feeding behavior, offspring from high-fat-sucrose 
fed dams presented higher weight in both sexes since day 7 of life (p < 0.001). On the other side,  
we have previously reported on adult male and female Wistar rats the protective effect on liver fat 
accumulation of methyl donor supplementation [17,18]. However, no differences were found as a 
result of maternal supplementation with methyl donors, which could be the result of the early stage of 
liver steatosis, the physiological status of the growth period or the different method of administration 
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of these compounds. Factors affecting the basis of offspring metabolic encoding, perinatal adverse 
nutritional feeding and early postnatal diet, are involved in the onset of many chronic adult diseases, 
such as obesity, insulin resistance or hypertension [1,16,24]. Thus, maternal nutrition could program 
gene expression patterns to the offspring that persist into adulthood and may contribute to the 
appearance of typical metabolic syndrome features such as hypertension, insulin resistance, 
hyperlipidemia and abdominal obesity [24]. On the other hand, total maternal energy intake (Kcal) 
during the lactation period (Figure 2a) was higher when mothers were fed the HFS diet (40%;  
p < 0.001). Interestingly, this extra energy intake was mainly spent in offspring growth (Figure 2b), 
which could be a natural adaptive mechanism for progeny survival expectance [25]. 
Figure 1. Body weight (a); length (b); body fat mass (c) and liver fat mass (d) from male 
and female offspring depending on maternal nutrition during lactation. Data are reported as 
means ± SE (n between 6 to 8 from each experimental group). C, control; C supp,  
control supplemented; HFS, high-fat-sucrose; HFS supp, high-fat-sucrose supplemented;  
*** p < 0.001. 
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Figure 2. Maternal energy intake during lactation (a) and energy consumption per 
offspring weight (b). Data are reported as means ± SE (n = 8 from each experimental group). 
C, control; C supp, control supplemented; HFS, high-fat-sucrose; HFS supp, high-fat-sucrose 
supplemented; *** p < 0.001. 
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2.2. Plasma Biochemical Markers 
The alteration of plasma lipid profile due to an obesogenic diet intake is a key feature from 
experimental models of diet-induced obesity, both on adult [26] or maternal perinatal feeding [24]. 
Regarding male offspring biochemical plasma variables (Table 2), total and HDL cholesterol levels 
were augmented (23% and 20% respectively; p < 0.001) in the HFS groups. Furthermore, maternal 
HFS feeding also increased triglycerides (50%; p < 0.01) and free fatty acid (60%; p < 0.01) plasma 
values. Female offspring showed similar alterations due to maternal HFS feeding, which included 
higher total (24%; p < 0.001) and HDL cholesterol (13%; p < 0.05) levels, and free fatty acids (55%;  
p < 0.01), as well as a trend to increase LDL cholesterol (20%; p < 0.1) and triglyceride (58%; p < 0.1) 
plasma levels. However, we have to be cautious as plasma was obtained without an overnight fasting, 
but animals were fasted about 4 h before the sacrifice.  
On the other hand, maternal supplementation with methyl donors altered plasma cholesterol profile 
of male offspring, increasing total (13%; p < 0.05) and LDL levels (23%; p < 0.01) and trending to 
increase HDL (8%; p < 0.1) cholesterol levels. The female offspring glucose levels also increased (8%;  
p < 0.05) by the maternal administration of methyl donor substrates, while total cholesterol also 
showed a trend to increase in these groups (10%; p < 0.1). In this way, previous studies with adult 
male Wistar rats have described increased plasma cholesterol-related parameters using the same 
methyl cocktail [17]. However, it is unclear if the increase of both cholesterol fractions had a 
protective effect and new studies are necessary to unravel the underlying mechanisms. Further analysis 
of our model could be focused on pancreas development, insulin secretion or glucose tolerance in 
order to decipher the causes of the increased glucose levels found in female offspring. 
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Table 2. Offspring biochemical plasma values depending on maternal nutrition during lactation. 
 C C supp HFS HFS supp 
2 × 2 ANOVA 
DIET SUPPL DIET × SUPPL 
Male offspring plasma values        
Glucose (mg/dL) 141.3 ± 6.1 140.9 ± 1.6 141.2 ± 3.6 151.7 ± 5.9 n.s. n.s. n.s. 
Total cholesterol (mg/dL) 111 ± 4 122 ± 8 132 ± 7 155 ± 4 *** * n.s. 
HDL cholesterol (mg/dL) 29.0 ± 1.7 31.5 ± 1.9 34.9 ± 1.2 38.1 ± 1.0 *** 0.077 n.s. 
LDL cholesterol (mg/dL) 65.4 ± 4.9 74.6 ± 6.4 65.1 ± 6.1 88.1 ± 2.0 n.s. ** n.s. 
Triglycerides (mg/dL) 83 ± 12 80 ± 13 109 ± 13 134 ± 14 ** n.s. n.s. 
Free fatty acides (mg/dL) 0.47 ± 0.10 0.45 ± 0.04 0.81 ± 0.11 0.66 ± 0.05 ** n.s. n.s. 
Females offspring plasma values        
Glucose (mg/dL) 132.6 ± 4.6 148.8 ± 3.7 141.0 ± 5.4 145.8 ± 3.2 n.s. * n.s. 
Total cholesterol (mg/dL) 110 ± 3 126. ± 11 142. ± 6 149 ± 4 *** 0.063 n.s. 
HDL cholesterol (mg/dL) 28.2 ± 1.2 31.9 ± 2.1 34.1 ± 1.6 33.6 ± 0.8 * n.s. n.s. 
LDL cholesterol (mg/dL) 62.8 ± 2.2 75.6 ± 7.3 80.0 ± 6.1 83.8 ± 7.8 0.051 n.s. n.s. 
Triglycerides (mg/dL) 95 ± 15 91 ± 23 137 ± 30 157 ± 43 0.092 n.s. n.s. 
Free fatty acides (mg/dL) 0.56 ± 0.05 0.36 ± 0.08 0.75 ± 0.09 0.73 ± 0.08 ** n.s. n.s. 
Data are reported as means ± SE (n between 6 to 8 from each experimental group). C, control; C supp, Control supplemented; HFS, high-fat-sucrose; HFS supp,  
high-fat-sucrose supplemented; n.s., non significative; * p < 0.05; ** p < 0.01; *** p < 0.001. 
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Abnormally high homocysteine plasma levels are strongly associated with increased cardiovascular 
risk features [27]. In this sense, Figure 3 shows an increase in homocysteine plasma levels due to 
maternal HFS diet in both sexes (179% in males and 87% in females; p < 0.001). Interestingly, 
maternal methyl donor supplementation reduced this adverse dietary effect and protected against this 
increase of homocysteine plasma concentrations in both males (−33%; p < 0.05) and females (−22%;  
p < 0.05). Stages of high homocysteine rates are usually accompanied by micronutrient deficiencies of 
vitamin B12 and folic acid, as well as with an overweight or obese status [28]. When cardiovascular 
problems are established, vitamin supplementation can decrease plasma homocysteine concentrations 
although it is not clear if cardiovascular risk is decreased at the same time [12,29]. For this reason,  
this novel approach is based on a preventive effect during early life instead of treating an already 
established stage of hyperhomocysteinemia. Further studies should be focused on the pathology and 
functionality of the cardiovascular system during adulthood in order to deepen our understanding of 
the potential role of maternal methyl donor supplementation on the cardiovascular system, and the use 
of homocysteine as a predisposing factor of disease risk [30,31]. Concerning the possible implicated 
mechanism, it is unclear if methyl donors exert a direct effect on homocysteine-related metabolic 
pathways or also regulate homocysteine metabolism by affecting DNA methylation [32,33]. 
Figure 3. Homocysteine plasma concentration from male and female offspring depending 
on maternal nutrition during lactation. Data are reported as means ± SE (n between 6 to 8 
from each experimental group). C, control; C supp, control supplemented; HFS,  
high-fat-sucrose; HFS supp, high-fat-sucrose supplemented; different letters indicate 
differences between groups of at least 0.05. 
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2.3. DNA Methylation Metabolism 
2.3.1. Hepatic Global DNA Methylation 
With regard to epigenetic-related features, maternal HFS feeding did not affect hepatic global DNA 
methylation (Figure 4). However, in the female offspring, maternal methyl donors supplementation 
decreased liver global DNA methylation (−6%; p < 0.05). Decreases in global hepatic DNA 
methylation due to folic acid supplementation have been previously reported in animal studies [17,34]. 
However, other studies did not find changes in liver global DNA methylation levels when mothers 
were supplemented with folic acid [35] or even after six generations of choline, betaine, metionine, 
zinc, folic acid and vitamin B12 supplementation [36]. The effect of these substrates plus an obesogenic 
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diet during perinatal periods influenced the offspring organs and cells in a sex-dependent manner [37]. 
The absence of changes in global DNA methylation does not necessary mean no changes in DNA 
methylation profile, since epigenome plasticity could activate methylation and demethylation 
processes at the same time [38,39]. Although molecular mechanisms underlying global DNA 
methylation are still uncertain, it is remarkable that promethylating substrates supplemented with the 
diet are not the final donors of methyl groups, but S-adenosylmethionine [40]. 
Figure 4. Hepatic global DNA methylation from male and female offspring depending on 
maternal nutrition during lactation. Data are reported as means ± SE (n = 6 from each 
experimental group). C, control; C supp, control supplemented; HFS, high-fat-sucrose; 
HFS supp, high-fat-sucrose supplemented; * p < 0.05. 
♂ ♀
 
2.3.2. Hepatic DNA Methyltransferases mRNA Expression 
With respect to hepatic mRNA expression of DNA methylation-related genes in the offspring 
(Figure 5), maternal HFS diet during lactation decreased male Dnmt3a (−32%; p < 0.001) expression 
levels and trended to increase those of Dnmt3b (20%; p = 0.662), which were significantly increased in 
females (19%; p < 0.05). Although Dnmt3a and Dnmt3b reported opposite expression patterns as a 
result of maternal obesogenic dietary intake, previous studies have shown distinct final phenotypes and 
developmental differences in Dnmt3a and Dnmt3b knock-out animals, suggesting different and 
independent roles of both enzymes [41,42]. Indeed, other studies have described specific regions 
preferentially methylated by Dnmt3a by using methylation-sensitive restriction fingerprinting [43]. 
However, mutations in human Dnmt3b gene have been linked with immunodeficiency, centromere 
instability, and facial anomalies (ICF) syndrome [44]. The increase of Dnmt3a in both sexes  
could be related with an activation of one carbon metabolic pathway, which could be associated  
with hyperhomocysteinemia and increased S-adenosylmethionine, which activates DNA methyl  
transfer-related enzymes [12,19,40]. 
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Figure 5. Liver mRNA levels from DNA methyltransferases from male and female 
offspring depending on maternal nutrition during lactation. Data are reported as  
means ± SE (n = 6 from each experimental group). C, control; C supp, control 
supplemented; HFS, high-fat-sucrose; HFS supp, high-fat-sucrose supplemented;  
T, p < 0.1; * p < 0.05; *** p < 0.001; AU, Arbitrary Units. 
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Finally, It has been previously suggested that liver DNA methylation capacity could be decreased 
when Aldo-homocysteine intracellular concentration is increased, since this metabolite is associated 
with plasma hyperhomocysteinemia [12,45]. In this sense, the results of Dnmt3a mRNA levels and 
plasma homocysteine values showed a noteworthy inverse correlation in both sexes (Figure 6)  
(r value = −0.485; p < 0.001), reinforcing the association hypothesis between DNA methylation and 
homocysteine metabolism. Contrariwise, hepatic Dnmt3b mRNA levels were not correlated with 
plasma homocysteine concentrations, which could be due to the different specific roles of both 
enzymes. Furthermore, the Dnmt3b statistical p value (marginally significant) and fold changes make it 
necessary to be cautious with the interpretation of these data. 
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Figure 6. Correlation analysis between plasma homocysteine levels (µmol/L) and hepatic 
Dnmt3a mRNA levels (AU). Male rats are represented by squares and females by crosses. 
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Although most of the confounding factors influencing the applied animal perinatal models were 
controlled, there could be additional features that affected the study such as the lack of maternal 
plasma lipid and homocysteine values or heart histological studies. Other limitations could be the use 
of the Friedewald equation in animals without an overnight fasting or the difficulty to extrapolate this 
research model to humans. 
3. Experimental Section  
3.1. Animal, Diets and Experimental Design 
A total of 32 female twelve-week-old Wistar rats (initial body weight 255 ± 5 g) supplied by the 
Applied Pharmacobiology Center (CIFA, Pamplona, Spain) were housed at 22 °C with controlled 
lighting (12 h light-dark cycle) and ad libitum access to food and water. They were mated with  
age-matched Wistar males (CIFA, Pamplona, Spain). After 21 days of pregnancy, excess pups in each 
litter were removed to keep 8 pups per dam (four males and four females, when possible) as described 
elsewhere [46] and mothers were randomized to four different dietary groups; control diet (C, n = 8), 
control diet supplemented with methyl donors (C supp, n = 8), high-fat-sucrose diet (HFS, n = 8) and 
high-fat-sucrose diet supplemented with methyl donors (HFS supp, n = 8). Control diet groups were 
fed a standard chow diet (2014 Teckland Global 14% Protein Rodent Maintenance Diet,  
Harlan Iberica, Barcelona, Spain) containing 20% of energy as protein, 67% as carbohydrate (7% as 
simple sugars) and 13% as lipid, whereas HFS groups were fed an obesogenic diet (D12451,  
Research Diets, New Brunswick, NJ, USA) containing 20% of energy as protein, 35% as 
carbohydrates (17% as sucrose) and 45% as lipid. Both diets are designed for a balanced micronutrient 
composition. Methyl donor supplementation cocktail contains betaine (5 g/kg diet, Sigma Aldrich, St. 
Louis, MO, USA), choline (5.37 g/kg diet, Sigma Aldrich, St. Louis, MO, USA), folic acid (5.5 mg/kg 
diet, Sigma Aldrich, St. Louis, MO, USA) and vitamin B12 (0.5 mg/kg diet, Sigma Aldrich, St. Louis, 
MO, USA), as described previously [16–18]. Mothers were fed ad libitum during 21 days of lactation. 
At this time, offspring body weight and length were assessed after anesthesia, whereas total fat mass 
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was measured. At the end of the experimental process (21 days) the offspring were euthanized by 
decapitation (n between 6 to 8 males and females randomly selected 6–7 litters per maternal dietary 
group), blood collected and plasma stored at −20 °C, and liver was dissected, weighted and stored at 
−80 °C for later analysis. All the procedures were performed in agreement with the National and 
Institutional guidelines of the Animal Care and Use Committee at the University of Navarra. 
3.2. Total Body and Liver Fat Content 
Total fat mass was measured by using an EchoMRI analyzer (Echo Medical Systems, Houston, TX, 
USA), a quantitative magnetic resonance technique [47]. Scans were performed by placing animals 
into a thin-walled cylinder with a plastic insert added to limit movement. Liver fat content was 
measured with a special adaptor for tissue sample scanning, as described by the manufacturer  
(Echo Medical Systems, Houston, TX, USA). 
3.3. Plasma Analysis 
Plasma glucose (HK-CP kit; ABX diagnostics, Montpellier, France), total cholesterol  
(Cholesterol-CP; ABX diagnostics, Montpellier, France), HDL cholesterol (HDL direct-CP; ABX 
diagnostics, Montpellier, France), triglycerides (Triglycerides; Randox Laboratories Ltd, Crumlin, 
UK), free fatty acids (FFA) (NEFA-HR-2 kit; WAKO Chemicals GmbH, Neuss, Germany) and 
homocysteine levels (Homocysteine Enzymatic Assays; Demeditec Diagnosis, Kiel, Germany)  
were measured using an automated ABX Pentra C200 equipment (Horiba ABX  
Diagnostics, Montpellier, France). LDL cholesterol levels were estimated by the Friedewald equation  
(LDLc = Total cholesterol − HDLc − TG/5) [48]. 
3.4. DNA and RNA Isolation 
Liver DNA and RNA were extracted (n = 6 animals from 5–6 litters per maternal dietary group) 
using the QIAamp DNA and RNA mini Kit (Qiagen GmbH, Hilden, Germany). Hepatic DNA 
concentration was quantified with PicoGreen DNA Quantification Reagent (Invitrogen, Milpites, CA, 
USA) and RNA levels with a Nanodrop 1000 Spectrophotometer (Thermo & Scientific, Wilmington, 
DE, USA). RNA was treated with DNase using RNeasy Micro Kit (Qiagen GmbH, Hilden, Germany) 
and retrotranscripted into cDNA for later analysis with Ambion WT Expression Kit (Ambion, 
Carlsbad, CA, USA). 
3.5. Global DNA Methylation 
Global DNA methylation was measured using the [3H]dCTP extension assay. Briefly, about  
300 ng of genomic DNA (n = 6 animals from 5–6 L per maternal dietary group) were digested 
overnight by triplicate with HpaII or MspI endonuclease enzymes (New England Biolabs, Ipswich, 
MD, USA). Another aliquot was incubated without enzymes as control. The single nucleotide 
extension reaction was performed in a 28 µL reaction mix incubated at 56 °C during 1 h containing 
280 ng of DNA, 1X PCR Gold Buffer, 1.0 mM MgCl2, 0.28 U of Ampitaq Gold polymerase  
(Applied Biosystems, Houston, TX, USA) and 0.38 µL dCTP[5-3H] (American Radiolabeled Chemicals,  
Int. J. Mol. Sci. 2013, 14 24433 
 
 
Saint Louis, MI, USA). Twenty-five microlitres from each reaction were applied on Whatman DE-81 
ion-exchange filters (Whatman, Kent, UK) and air-dried for 1.5 h. Then, filters were washed  
three times with Sodium-Phosphate buffer (0.5 M, pH 7.0) and radioactivity levels were measured by 
liquid scintillation counting (Wallmac 1409, Pharmacia, Uppsala, Sweden). Background results were 
subtracted from enzyme-treated samples and global DNA methylation calculated as previously 
described [49]. 
3.6. Real-Time qPCR 
Quantitative real-time PCR (n = 6 animals from 5–6 L per maternal dietary group) was performed 
by triplicate using ABI PRISM 7900 HT Fast real-time PCR system (Applied Biosystems, Austin, TX, 
USA) and Taqman primers (Applied Biosystems, Austin, TX, USA) for Dnmt1 (Rn00709664_m1*), 
Dnmt3a (Rn01027162_g1*) and Dnmt3b (Rn01536419_m1). Fold change between groups was 
calculated using the 2−ΔΔCt method. cDNA integrity was checked with 18S (Hs99999901_s1) probe and 
gene expression levels were normalized with respect to beta-actin (Rn00667869_m1*) as internal control. 
3.7. Statistical Analysis 
Results are expressed as means ± standard error (SE). Maternal features during pregnancy and 
before lactation were assessed using one way ANOVA. Offspring outcomes were assessed using  
2 × 2 factorial ANOVA tests (Diet × Supplementation); effect of obesogenic diet intake (C + C supp 
vs. HFS + HFS supp) plus the effect of Supplementation (C + HFS vs. C supp + HFS supp).  
This statistical test is also able to define interactions between both factors by DMS post hoc test for 
multiple comparisons. Male and female offspring were separately analyzed due to sexual dimorphism. 
Pearson’s rank correlation was also used to analyze Dnmt3a liver mRNA and plasma homocysteine 
levels potential association. The statistically significant probability was set at p < 0.05. All the 
statistical analyses were performed with SPSS 15.0 program for Windows (SPSS, Chicago, IL, USA). 
4. Conclusions  
In conclusion, maternal high-fat sucrose dietary intake during lactation could program  
offspring obesity-related physiological features in both sexes. Interestingly, maternal supplementation 
with a micronutrient cocktail based on methylation donor substrates appears to protect against  
plasma hyperhomocysteinemia, probably affecting key metabolic enzymes involved in the  
methionine-homocysteine cycle. 
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